These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 171132)
1. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)]. Rössler R Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132 [TBL] [Abstract][Full Text] [Related]
2. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder. Norby L; Mark AL; Kaloyanides GJ Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467 [TBL] [Abstract][Full Text] [Related]
3. Aldosterone and other mineralocorticoids in Bartter's syndrome. Saruta T; Fujimaki M; Senba S; Saito I; Konishi K J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989 [TBL] [Abstract][Full Text] [Related]
4. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome. Horký K; Schreiber V; Dvoráková J Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182 [TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man. Klemm SA; Tunny TJ; Gordon RD J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin suppresses plasma aldosterone concentration in a case of Bartter's syndrome. Shigeta H; Tasaki N; Kitazumi S; Kitagawa Y; Nakano K; Kanatsuna T; Kondo M Endocrinol Jpn; 1987 Apr; 34(2):309-12. PubMed ID: 2887425 [TBL] [Abstract][Full Text] [Related]
7. [Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)]. Ploier R; Tulzer W Wien Med Wochenschr; 1981; 131(11):287-93. PubMed ID: 7020264 [TBL] [Abstract][Full Text] [Related]
9. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)]. Klaus D; Witzgall H; Zehner J; Dürr H; Lange H Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592 [TBL] [Abstract][Full Text] [Related]
10. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163 [TBL] [Abstract][Full Text] [Related]
11. Bartter's syndrome. New insights into pathogenesis and treatment. Solomon RJ; Brown RS Am J Med; 1975 Oct; 59(4):575-83. PubMed ID: 1166859 [TBL] [Abstract][Full Text] [Related]
12. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder. Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289 [TBL] [Abstract][Full Text] [Related]
13. The role of prostaglandins in Bartter's syndrome. Winterborn MH; Hewitt GJ; Mitchell MD Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882 [TBL] [Abstract][Full Text] [Related]
14. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure. Nicholls MG; Espiner EA; Donald RA J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213 [TBL] [Abstract][Full Text] [Related]
15. [Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)]. Floret D; David M; Roux A; Hage GN; Teyssier G Nouv Presse Med; 1979 Jan; 8(1):17-21. PubMed ID: 122007 [TBL] [Abstract][Full Text] [Related]
16. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake]. Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254 [No Abstract] [Full Text] [Related]
19. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy. Wisgerhof M J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794 [TBL] [Abstract][Full Text] [Related]